Lynch syndrome

Lynch syndrome (HNPCC or Hereditary nonpolyposis colorectal cancer ) is an autosomal dominant genetic condition which has a high risk of colon cancer as well as other cancers including endometrium, ovary, stomach, small intestine, hepatobiliary tract, upper urinary tract, brain, and skin. The increased risk for these cancers is due to inherited mutations that impair DNA mismatch repair.

Increasing the age limit for Lynch syndrome genetic testing may save lives

GPs want more support to prescribe cancer prevention drugs

Patient study suggests broader genetic testing for colorectal cancer risk

Genetic counseling helps determine risk for hereditary cancers

New cancer type with PIK3CA mutations

Dietary experiments in mice point the way to early detection of cancer in humans

Increased risk of large bowel cancer for each one cm rise in waist circumference

AGA recommends all patients with colorectal cancer get tested for Lynch syndrome

New strategy improves detection of genetic mutations in hereditary colorectal cancer

Aspirin reverses obesity cancer risk

Association between genetic condition, hormonal factors, and risk of endometrial cancer

Risk of bowel cancer reduced by taking aspirin for Lynch syndrome patients

High risk of bowel cancer for gene carriers

Genetic test would help 'cut bowel cancer spread'

Genetic testing of tumor is recommended for colorectal cancer patients

Study provides clearer picture of cancer risk

Study allows better prediction of the risk of hereditary cancer

New genetic screening test for Lynch Syndrome

Evidence mounts for endometrial cancer tumor testing to identify women with Lynch syndrome

Mutua Madrileña funds IDIBELL and ICO project to improve diagnosis of Lynch syndrome

Health & medical news – free subscription